BioNTech

Historical price data

BioNTech SE is a pioneering German biotechnology company founded in 2008 with a mission to translate immunological science into life-saving immunotherapies and vaccines. Its historic achievement was the co-development and global commercialization of the first approved mRNA-based COVID-19 vaccine, Comirnaty, with Pfizer, which validated its core platform and provided substantial financial and operational resources. The company is now strategically deploying its validated mRNA technology, alongside complementary modalities like bispecific antibodies, to build a deep and diversified oncology pipeline while advancing next-generation vaccines for infectious diseases.

A proprietary and integrated mRNA therapeutic platform, featuring optimized mRNA constructs, lipid nanoparticle (LNP) delivery systems, and scalable manufacturing, enabling both personalized and off-the-shelf vaccines and immunotherapies.